Biocredit Rapigen One Step Rapid Test

Biocredit Covid-19 Ag Detection Kit


Lateral motion immunochromatographic assay that adopted twin color system.
For the qualitative detection of SARS-CoV-2 antigen from nasopharyngeal swab specimen.
The examine incorporates colloid gold conjugate pad and a membrane strip pre-coated with antibodies explicit to SARS-CoV-2 antigen on the examine traces (T).
A visible black band (antibody-antigen-antibody gold conjugate sophisticated) appears on the examine traces (T) If SARS-CoV-2 antigen is present throughout the specimen.
The administration line (C) reveals that examine is carried out appropriately.
Evaluated with panel specimen (n = 75) by PCR
Sensitivity: 90,2 %
Specificity: 100 %


AVAILABILITY:In Stock with The Lowest Price throughout the Market

SHIPMENT:Related Day Cargo Orders Sooner than 14

H00SIZE:20 Exams/KitSPECIFICITY:98.90%


Immunochromatography speedy examine

Guidance for use of VITROS SARS CoV2 Antigen CLIA based totally Examine from Ortho Medical


1. The VITROS SARS CoV2 Antigen assay is a chemiluminescent immunoassay meant for the qualitative
detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal (NP) specimens from individuals who
are suspected of COVID-19 inside one to five days of the onset of indicators, or mid-turbinate specimens
collected from asymptomatic individuals.
2. The assay should be carried out in VITROS 3600 Immunodiagnostics system or VITROS 5600 / VITROS XT 7600
Constructed-in system from Ortho.


COVID-19, Nasopharyngeal swabs

Calibration Fluctuate


Biocredit Antigen Test
Biocredit Antigen Take a look at

VITROS SARS CoV2 antigen assay – Procedural Steps: –

Stage 1: Nasopharyngeal swab specimen assortment:
1. Purchase a nasopharyngeal swab specimen by inserting the sterile swab into the nostril.
2. Push the sterile swab until resistance is met on the stage of the turbinate.
3. Rotate the sterile swab various events in direction of the nasopharyngeal wall & go away throughout the place for
10 seconds to saturate the swab tip.
4. Take away the swab from the nostril fastidiously.
5. Place the swab specimen into the viral transport medium buffer tube and shut the tube tightly.
6. Transport the swab sample in VTM to the laboratory in a cold chain.
7. The sample could possibly be saved in Room temperature (Beneath 30◦C) for as a lot as 24 hrs from the time of
sample assortment or at 2 – 8◦C for as a lot as 48 hrs from the time of sample assortment.

Stage 2: Sample preparation for testing:

1. Sample preparation have to be carried out in BSL-2 stage cabinet throughout the Laboratory.
2. Mix the swab specimen in VTM tube properly (vortex roughly 3-5 seconds).
3. Swap 100 μL VITROS SARS-CoV-2 Antigen Extraction Buffer proper right into a labelled new sample tube.
4. Add 400 μL viral sample to the above tube (to care for 1:4 ratio of extraction buffer: sample)
5. Mix properly (Cap/Plug the sample tube and vortex roughly 3-5 seconds).

COVID-19 Panbio™ COVID-19 Ag Rapid Test Device

EUR 220

COVID-19 Ag Rapid Test, Cs

R0182C 20
EUR 1.25

COVID-19 Ag Self-Test. Cs

R0182CST 1,2,5
EUR 1.65

COVID-19 Ag Rapid Test External Control Kit

C0182 each
EUR 520

Flu A & Flu B & Covid-19 Ag Rapid Test

GF101A3 25 Test/kit Ask for price

Panbio COVID-19 AG RAPID T Device 25T NP

41FK10 25 Tests/Kit
EUR 220


41FK11 25 Tests/Kit
EUR 123.75
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

COVID-19 + Influenza A. B Ag Rapid Test, Cs

R0188C 1fi Ask for price

COVID-19 Ag Detection Kit (Colloidal Gold Immunochromatography)

MBS398097-20Tests 20Tests
EUR 325

Truenat™ COVID-19

601430005 5T
EUR 60

Truenat™ COVID-19

601430020 20T
EUR 240

Truenat™ COVID-19

601430050 50T
EUR 600

COVID-19 variant pack

SB072 0.5
EUR 2325.81
Description: SARS-CoV-2 Spike (S) glycoprotein:Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein in a class I fusion protein that allows the virus to enter host cells.Variants package available:Some proteins of Sars-CoV-2 are identified as leading targets for COVID-19 therapies. SB-PEPTIDE offers a special pack pre-made peptide libraries of Spike protein including peptides from COVID-19 variants: UK COVID-19 variant B.1.1.7, South Africa COVID-19 variant B.1.351, Brazil COVID-19 variant B.1.1.248. SB-PEPTIDE offers additional plate containing only peptides with Spike S protein mutation of COVID-19 B.1.1.7, B. and B.1.1.248 (cited below).Variants package and Spike (S) glycoprotein peptide library can be used for T-cell assays, immune monitoring, antigen specific T-cell stimulation, T-cell expansion and cellular immune response.

COVID-19 Spike Antigen

30-2018 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

COVID-19 Spike Antigen

30-2019 1 mg
EUR 400
Description: COVID-19 Spike recombinant antigen

Moderna COVID-19 Vaccine

H7N7-319 1 vial
EUR 798.4
Description: Protein

SARS & COVID-19 coronavirus

3862 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3863 each
EUR 330
Description: nucleoprotein

SARS & COVID-19 coronavirus

3864 each
EUR 330
Description: nucleoprotein

COVID-19 Negative Control

MBS412771-05mL 0.5mL
EUR 100

COVID-19 Negative Control

MBS412771-5x05mL 5x0.5mL
EUR 305

COVID-19 Nucleocapsid protein

30-2005 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant antigen

COVID-19 Nucleocapsid protein

30-2006 1 mg
EUR 700
Description: COVID-19 Nucleocapsid protein recombinant Antigen

Leave a Comment

Your email address will not be published. Required fields are marked *